Optimising thrombolytic therapy in elderly patients with acute myocardial infarction

Drugs and Aging

Volumn 8, Issue 1, 1996, Pages 17-22

  Verstraete, Marc ^a   Collen, Desiré ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANISTREPLASE; FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; BRAIN HEMORRHAGE; CLINICAL TRIAL; FIBRINOLYTIC THERAPY; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK; RISK BENEFIT ANALYSIS; SYMPTOMATOLOGY;

EID: 0030030483     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199608010-00004     Document Type: Review

References (32)

1. Weaver WD, Litnin PE, Martin JS, et al. The MITI Project Group. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. J Am Coll Cardiol 1991; 18: 675-762
2. Pfeiffer MA, Moyé LA, Braunwald E, et al. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. JAMA 1991; 266: 528-32
3. Sherry S, Marder V. Mistaken guidelines for thrombolytic therapy of acute myocardial infarction in the elderly. J Am Coll Cardiol 1991; 17: 1237-8
4. Yang XS, Willems JL, Pardaens J, et al. Acute myocardial infarction in the very elderly: a comparison with younger age groups. Acta Cardiol 1987; 42: 59-68
5. Gurwitz JH, Goldberg RJ, Gore JM. Coronary thrombolysis for the elderly? JAMA 1991; 265: 1720-3
6. Montague TJ, Ikuta RM, Wong RY, et al. Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two-year period (1987-1989). Am J Cardiol 1991; 68: 843-7
7. Sleight P. Is there an age limit for thrombolytic therapy? Am J Cardiol 1993; 72: 30G-33G
8. Ketley D, Woods KL. Age limits the use of thrombolytic drugs for acute myocardial infarction in most European countries [abstract]. Eur Heart J 1995; 16: 10
9. GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-82
10. Katz A, Cohn G, Mashal A, et al. Thrombolytic therapy for acute myocardial infarction in a 110-year old man. Am J Cardiol 1993; 71: 1122-3
11. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarcto Miocardio (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986 Feb 22; 1(8478): 397-401
12. ISIS-2 (Second International Study of Infarct Survival Collaborative Group). Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988 Aug 13: 2(8607): 349-60
13. Battershill PE, Benfield P, Goa KL. Streptokinase: a review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients. Drugs Aging 1994; 4(1): 63-86
14. Fibrinolysis Therapy Trialists (FFT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity, results from all randomized trials of more than 1,000 patients. Lancet 1994; 343: 311-21
15. Mauri F, de Brase M, Franzosi MG, et al. In hospital causes of death in the patients admitted to the GISSI study. G Ital Cardiol 1987; 17: 37-44
16. Becker RC, Charlesworth A, Wilcox RG, et al. Cardiac rupture associated with thrombolytic therapy: impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (LATE) study. J Am Coll Cardiol 1995; 25: 1063-8
17. Collins R. Optimizing thrombolytic therapy of acute myocardial infarction: age is not a contraindication [abstract]. Circulation 1991; 84: II230
18. De Jaegere PP, Arnold AA, Balk AH, et al. Intracranial hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factors. J Am Coll Cardiol 1992; 19: 289-94
19. Simoons ML, Maggioni AP, Knatterud GP, et al. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet 1993; 342: 1523-8
20. Gore JM, Sloan M, Price TR, et al. Intracerebral hemorrage. Cerebral infarction and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the TIMI II pilot and clinical trial. Circulation 1991; 83: 448-59
21. Kase CS, O'Neal AM, Fisher M, et al. Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis. Ann Intern Med 1990; 112: 17-21
22. O'Connor CM, Califf RM, Massey EW, et al. Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long term prognosis. J Am Coll Cardiol 1990; 16: 553-60
23. Mooradd M, Goldberg RJ, Gore JM. Thrombolytic therapy in the elderly patients. In: Becker RC, editor. The modern era of coronary thrombolysis. Boston: Kluwer Academic Publishers, 1994: 163-74
24. AIMS trial study group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988; 1: 545-9
25. Wilcox RG, von der Lippe G, Olsson G, et al. Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombosis. Lancet 1990 May 19; 335: 1175-8
26. Feit F, Breed J, Anderson JL, et al. A randomized, placebo-controlled, trial of tissue plasminogen activator in elderly patients with acute myocardial infarction [abstract]. Circulation 1990; 82 Suppl.: III-666
27. White H, Cross D, Scott M, et al. Comparison of effects of thrombolytic therapy on left ventricular function in patients over with those under 60 years of age. Am J Cardiol 1991; 67: 913-8
28. LATE study group. Late assessment of thrombolytic efficacy (LATE) study with alteplase in 6-24 hours after onset of acute myocardial infarction. Lancet 1993; 342: 759-66
29. Chaitman BR, Thompson B, Wittry MD, et al. The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. J Am Coll Cardiol 1989; 14: 1159-65
30. Anderson JL, Karagounis L, Allen A, et al. Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis. Am J Cardiol 1991; 68: 166-70
31. Tabone X, Vacheron A. La thrombolyse après 75 ans; bénéfices, risques, indications [in French]. Arch Mal Coeur Vaiss 1995; 88: 255-60
32. Califf RM, Topol EJ, George BS, et al. Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction. Am J Med 1988; 85: 353-9